Arjuna Therapeutics
Phase 1Arjuna Therapeutics is an emerging biotechnology leader developing an entirely novel class of small molecules, Therapeutic Molecular Clusters for cancer.
Founded
2020
Focus
Small Molecules
About
Arjuna Therapeutics is an emerging biotechnology leader developing an entirely novel class of small molecules, Therapeutic Molecular Clusters for cancer.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2020
LocationBarcelona, Spain
StagePhase 1
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile